[ij] [ij] [ij] 
Email id

Year : 2021, Volume : 14, Issue : 1
First page : ( 285) Last page : ( 288)
Print ISSN : 0974-3618. Online ISSN : 0974-360X.
Article DOI : 10.5958/0974-360X.2021.00051.2

Formulation and evaluation of solid lipid nanoparticle of felbamate for improved drug delivery

Samal Ramanuj Prasad*, Sahu Pratap Kumar

School of Pharmaceutical Sciences, Siksha ‘O’ Anusandhan University, Bhubaneswar, Odisha-751030, India

*Corresponding Author E-mail: ramanuj.samal@gmail.com

Online published on 22 April, 2021.


Solid lipid nanoparticles are typically spherical in shape with average size of 1-1000nm in diameter. These are the alternatives to traditional colloidal carrier systems such as emulsions, liposomes, microspheres etc. Felbamate is a PEGylated phenylcarbamate derivative that acts as an antagonist of NMDA receptors. It is used as an anticonvulsant, primarily for the treatment of seizures in severe refractory epilepsy. It is slightly soluble in water with t1/2 of 4–6 hours. Solid lipid nanoparticles of felbamate are prepared by using lipids (glyceryl monostearate and glyceryl monooleate) with tween 80 as stabilizer. The prepared nanoparticle formulations were evaluated for their entrapment efficiency, assay, in-vitro drug release, particle size analysis, and stability. A formulation containing glyceryl monooleate, stabilized with tween 80 as surfactant showed prolonged drug release, smaller particle size, and narrow particle size distribution, as compared to other formulations.



Colloidal carriers, Solid lipid nanoparticles, Lipid matrix, Surfactants, Entrapment efficiency.


║ Site map ║ Privacy Policy ║ Copyright ║ Terms & Conditions ║ Page Rank Tool
721,274,481 visitor(s) since 30th May, 2005.
All rights reserved. Site designed and maintained by DIVA ENTERPRISES PVT. LTD..
Note: Please use Internet Explorer (6.0 or above). Some functionalities may not work in other browsers.